Salarius Pharmaceuticals files prospectus supplement for $810,973 at-the-market offering

Decoy Therapeutics Inc.

At-the-market offering of up to $810,973 of common stock via Ladenburg Thalmann & Co. Inc.
Prospectus supplement filed July 22, 2024 under existing S-3 registration statement (File No. 333-266589).
Legal opinion of Hogan Lovells US LLP on share validity filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.